DLTR
58
-5
MU
79
4
KSS
58
-4
PCAR
56
4
KMX
38
-9
FITB
78
3
SWK
61
6
FLS
63
2
XRX
34
-4
HRL
35
12
NKE
31
-5
SWKS
48
-7
PH
64
2
CMI
75
4
GRMN
45
8
DHR
68
2
GE
77
5
CVS
40
3
YUM
58
2
PG
43
-2
DLTR
58
-5
MU
79
4
KSS
58
-4
PCAR
56
4
KMX
38
-9
FITB
78
3
SWK
61
6
FLS
63
2
XRX
34
-4
HRL
35
12
NKE
31
-5
SWKS
48
-7
PH
64
2
CMI
75
4
GRMN
45
8
DHR
68
2
GE
77
5
CVS
40
3
YUM
58
2
PG
43
-2
Financhill
Back

Invesco Bloomberg Analyst Rating Improvers ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
60

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:
$74.96
Seasonality Move:
5.42%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$38.36
Seasonality Move:
-16.78%
Buy
60
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

  • The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $75.17. The Score for UPGD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • UPGD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

  • The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $75.17
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing slight buying pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

UPGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.83 Buy
Relative Strength Index (14 RSI): 52.37 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.88 - 76.06) Buy
Bollinger Bands (100): (73.05 - 75.39) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

UPGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.94 Sell
20-day SMA: 75.16 Buy
50-day SMA: 74.21 Buy
200-day SMA: 71.97 Buy
8-day EMA: 47.98 Buy
20-day EMA: 24.98 Buy
50-day EMA: 11.2 Buy
200-day EMA: 2.97 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):